首页> 外国专利> FXIII DETECTION FOR VERIFYING SERUM SAMPLE AND SAMPLE SIZE AND FOR DETECTING DILUTION

FXIII DETECTION FOR VERIFYING SERUM SAMPLE AND SAMPLE SIZE AND FOR DETECTING DILUTION

机译:FXIII检测,用于验证血清样本和样本大小以及检测稀释度

摘要

Analyses of serum samples for the presence and amount of either of the twosubunits of human Factor XIII protein are used as a means of eliminating asignificant source of error that arises in the testing of serum and plasma.For serum samples, a negative result of an analysis for the presence ofsubunit a is a means of verifying that a sample is indeed serum, while anegative or positive result for subunit a serves to distinguish serum(negative) from plasma (positive). A positive result for the presence ofsubunit b is a means of verifying that the sample is either serum or plasmaand not any other biological fluid. A quantitative analysis of subunit b is ameans of verifying that the sample is of the intended volume rather thanhaving been reduced in volume due to improper sampling. A quantitativeanalysis of subunit b is also a means of verifying the dilution of a sample ofeither serum or plasma.
机译:分析血清样品中两者之一的含量和含量人类XIII因子蛋白的亚基被用作消除血清和血浆测试中出现的重要错误来源。对于血清样品,分析是否存在阴性结果a亚单位是一种验证样品确实为血清的方法,而a亚单位a的阴性或阳性结果有助于区分血清(阴性)来自血浆(阳性)。存在的积极结果b亚基是一种验证样品是血清还是血浆的方法而不是任何其他生物液体。亚基b的定量分析是验证样品是否达到预期体积的方法由于采样不当而导致体积减小。定量的b亚基的分析也是一种验证样品稀释度的方法血清或血浆。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号